EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microbubble-Protected Oncolytic Virotherapy Targeted by Sonoporation Induces Tumor Necrosis and T-Lymphocyte Infiltration in Humanized Mice Bearing Triple-Negative Breast Cancer

Juliana Sitta iD, Flavia De Carlo, Imani Kirven, John H Tackett iD, Patrice Penfornis iD, George Clement Dobbins, Mallory Barbier, Luis Del Valle iD, Clayton T Larsen, Ernest G Schutt, Rhodemann Li, Candace M Howard iD und 1 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Juliana Sitta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Mississippi Medical Center, Jackson, MS 39216, USA. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Triple Negative Breast Neoplasms, Microbubbles, Oncolytic Viruses. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Vesselon, John Ruckdeschel ISRP internal grant at UMMC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncolytic virotherapy has shown great promise in mediating targeted tumor destruction through tumor-selective replication and induction of anti-tumor immunity; however, obstacles remain for virus candidates to reach the clinic. These include avoiding neutralizing antibodies, preventing stimulation of the adaptive immune response during intravenous administration, and inducing sufficient apoptosis and immune activation so that the body’s defense can work to eradicate systemic disease. We have developed a co-formulation of oncolytic viruses (OVs) with Imagent® lipid-encapsulated, perfluorocarbon microbubbles (MBs) to protect the OVs from the innate and adaptive immune system. Once inside the MB, the viral particles become acoustically active such that external ultrasound can target the delivery of the virus locally within the tumor. Humanized NSG female mice (Hu-CD34+ NSG-SGM3) engrafted in their flanks with MDA-MB-231-Luc triple-negative breast cancer (TNBC) cells were transduced with MB/OVs, with or without adjuvant Pembrolizumab treatment, and tumor sizes and tumor necrosis were assessed. The presence of CD8+ (cytotoxic T-cells), CD4+ (helper T-cells), and CD25+ (Tregs) tumor-infiltrating lymphocytes (TILs) was quantified in the tumor samples by immunohistochemistry. In an in vivo model of humanized mice engrafted with a human immune system, we observed significantly greater tumor necrosis and smaller tumor mass in human TNBC xenografts systemically treated with MB/OV complexes in the presence or absence of pembrolizumab adjuvant treatment, compared to controls. Additionally, we observed a low ratio of CD4+/CD8+ TILs and a high ratio of CD8+/CD25+ TILs in the MDA-MB-231 xenografts treated with MB/OVs complexes with or without pembrolizumab adjuvant treatment, compared to controls. Our study demonstrated the feasibility of using MBs to target OVs to TNBC through diagnostic ultrasound, which decreased tumor mass by increasing tumor necrosis and stimulated a local and systemic antitumoral immune response by increasing intratumoral CD8+ T-cytotoxic lymphocyte infiltration and decreasing CD25+ Treg cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirotherapyTriple Negative Breast NeoplasmsMicrobubblesOncolytic VirusesAnimalsFemaleMiceHumansCell Line, TumorLymphocytes, Tumor-InfiltratingNecrosisXenograft Model Antitumor AssaysT-Lymphocytes

Stichwörter der Autor:innen

cavitationgene therapyimmunotherapymicrobubblesmicrospheresoncolytic virusultrasoundultrasound contrast agent

Autor:innen und Institutionen

  • Department of Radiology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
  • Department of Biomedical Sciences, Imaging Track, University of Mississippi Medical Center, Jackson, MS 39216, USA.
  • Department of Pharmacology & Toxicology, Cancer Center & Research Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
  • Department of Neurosurgery and Bioinformatics, University of Alabama Birmingham, Birmingham, AL 35205, USA.
  • Department of Pathology, Louisiana Cancer Research Center, Louisiana State University Health, New Orleans, LA 70112, USA.
  • Vesselon, Inc., Norwalk, CT 06851, USA.

ORCID-Profile: Juliana Sitta, John H Tackett, Patrice Penfornis, Luis Del Valle, Candace M Howard, Pier Paolo Claudio

Förderung

  • NIGMS NIH HHS
  • Vesselon
  • John Ruckdeschel ISRP internal grant at UMMC
  • Vesselon, Inc.
  • National Institute of General Medical Sciences of the National Institutes of Health
  • Molecular Histopathology & Analytical Microscopy Core at the Louisiana Cancer Research Center

Zitieren

APA

Sitta, J., De Carlo, F., Kirven, I., Tackett, J. H., Penfornis, P., Dobbins, G. C., Barbier, M., Del Valle, L., Larsen, C. T., Schutt, E. G., Li, R., Howard, C. M., & Claudio, P. P. (2024). Microbubble-Protected Oncolytic Virotherapy Targeted by Sonoporation Induces Tumor Necrosis and T-Lymphocyte Infiltration in Humanized Mice Bearing Triple-Negative Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413697

Vancouver

Sitta J, De Carlo F, Kirven I, Tackett JH, Penfornis P, Dobbins GC, et al. Microbubble-Protected Oncolytic Virotherapy Targeted by Sonoporation Induces Tumor Necrosis and T-Lymphocyte Infiltration in Humanized Mice Bearing Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413697

BibTeX
@article{Sitta2024,
  author = {Sitta, Juliana and De Carlo, Flavia and Kirven, Imani and Tackett, John H and Penfornis, Patrice and Dobbins, George Clement and Barbier, Mallory and Del Valle, Luis and Larsen, Clayton T and Schutt, Ernest G and Li, Rhodemann and Howard, Candace M and Claudio, Pier Paolo},
  title = {Microbubble-Protected Oncolytic Virotherapy Targeted by Sonoporation Induces Tumor Necrosis and T-Lymphocyte Infiltration in Humanized Mice Bearing Triple-Negative Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413697}
}
Kostenlos starten →